| Bioactivity | Palatrigine is a compound with angiotensin-converting enzyme inhibitory and beta-adrenergic receptor blocking properties[1][2]. |
| CAS | 98410-36-7 |
| Formula | C12H13Cl2N5 |
| Molar Mass | 298.17 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Allan G, et al. BW A256C, a chemically novel class 1 antiarrhythmic agent. A comparison of in vitro and in vivo activity with other class 1 antiarrhythmic agents[J]. British journal of pharmacology, 1986, 88(2): 333-343. [2]. Donoghue S, et al. Effects of BW A256C, a novel class 1 antiarrhythmic agent, on maximum rate of depolarisation of cardiac action potentials in vitro: frequency, use, and voltage dependence[J]. Journal of cardiovascular pharmacology, 1987, 9(1): 12-18. |